LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today reported the award of the previously announced stock dividend of RXi Pharmaceuticals Corporation (RXi) common shares to holders of CytRx common stock as of the record date for the distribution, which was the close of business (Eastern time) yesterday, March 6, 2008. CytRx expects that RXi common stock will be distributed on or about March 11, 2008, and RXi common shares are expected to begin trading following the distribution date on the NASDAQ Capital Market under the symbol “RXII.” CytRx continues to hold approximately 49% of RXi common stock.
